fda glp 1 shortage Navigating Access: The Future of Compounded GLP-1 Receptor Agonists for Weight Loss BREAKING: THE FDA WILL NOT

Diz-Chaves Y, Toba L, Fandio J, Gonzlez-Matas LC, Garcia-Segura LM, Mallo F

Rare Diseases - Glutathione Synthase Deficiency Glutathione synthase deficiency, or proglutamicaciduria, is the most severe form of glutathione deficiency

FoxP2 regulates neurogenesis during embryonic cortical development

In the medRxiv preprint (in collaboration with David Brook), we present the first global model of the impact GLP-1 drugs could have on people with diabetes, obesity, and cardiovascular disease

Researchers are currently exploring the potential of GLP-1 drugs to treat these conditions, and clinical trials are ongoing

IGF-1 LR3 is studied for its role as the major downstream signaling agent